Variations in the monoamine oxidase B (MAOB) gene are associated with Parkinson's disease

Movement Disorders

Volumn 14, Issue 2, 1999, Pages 219-224

  Mellick, George D ^a   Buchanan, Daniel D ^a   McCann, Sally J ^a   James, Kristy M ^a   Johnson, Anthony G ^a   Davis, Darren R ^a   Liyou, Nanay ^a   Chan, Daniel ^b   Le Couteur, David G ^c  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b PRINCE OF WALES HOSPITAL   (Australia)

^c CANBERRA HOSPITAL   (Australia)

Author keywords

Genetics; Monoamine oxidase B; Parkinson's disease; Polymerase chain reaction

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; DNA; REPETITIVE DNA;

AGED; ALLELE; ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; DNA POLYMORPHISM; FEMALE; GEL ELECTROPHORESIS; GENE FREQUENCY; GENOTYPE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REGRESSION ANALYSIS;

AGED; ANALYSIS OF VARIANCE; CASE-CONTROL STUDIES; COHORT STUDIES; DINUCLEOTIDE REPEATS; FEMALE; GENE DOSAGE; HUMANS; MALE; MONOAMINE OXIDASE; NEW SOUTH WALES; PARKINSON DISEASE; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; QUEENSLAND; STATISTICS;

EID: 0033407580     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/1531-8257(199903)14:2<219::AID-MDS1003>3.0.CO;2-9     Document Type: Article

References (26)

1. Weyler W, Hsu YP, Breakefield XO. Biochemistry and genetics of monoamine oxidase. Pharmacol Ther 1990;47:391-417.
2. Kochersperger LM, Parker EL, Siciliano M, Darlington GJ, Denney RM. Assignment of genes for human monoamine oxidase A and B to the X chromosome. J Neurosci Res 1986;16:601-616.
3. Kinemuchi H, Fowler CJ, Tipton KF. The neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and its relevance to Parkinson's disease. Neurochem Int 1987:11:359-373.
4. Kinemuchi H, Arai Y, Fowler CJ. A role for monoamine oxidase in the development of Parkinson's disease? In: Yasuhara H, ed. MAO and Parkinson's Disease. London: Academic Press, 1993: 127-135.
5. Langston JW, Forno LS, Rebert CS, Irwin I. Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the squirrel monkey. Brain Res 1984;292:390-394.
6. Strolin-Benedetti M, Dostert P. Monoamine oxidase brain aging and degenerative diseases. Biochem Pharmacol 1989;38:555-561.
7. Konradi C, Ozelius L, Breakefield XO. Highly polymorphic (GT)n repeat sequence in intron II of the human MAOB gene. Genomics 1992;12:176-177.
8. Kurth JH, Kurth MC, Poduslo SE, Schwankhaus JD. Association of monoamine oxidase B allele with Parkinson's disease. Ann Neurol 1993;33:368-372.
9. Ho SL, Kapadi AL, Ramsden DB, Williams AC. An allelic association study of monoamine oxidase B in Parkinson's disease. Ann Neurol 1995;37:403-405.
10. Kurth JH, Hubble JP, Eggers EA, Kurth MC, Koller WC, Lieberman AN. Lack of association of CYP2D6 and MAO-B alleles with Parkinson's disease in a Kansas cohort [Abstract]. Neurology 1995;45(suppl 4):A429.
11. Costa P, Checkoway H, Swanson PD, Costa LG. Monoamine oxidase B polymorphism in Parkinson's disease [Abstract]. Mov Disord 1996;11(suppl 1):181.
12. Calne DB, Snow BJ, Lee C. Criteria for diagnosing Parkinson's disease. Ann Neurol 1992;32(suppl):S125-S127.
13. Douglas AM, Georgalis AM, Benton LR, Canavan KL, Atchison BA. Purification of human leukocyte DNA: proteinase K is not necessary. Anal Biochem 1992;201:362-365.
14. Birkmayer W, Knoll J, Reiderer P, Youdim MB, Hars V, Marton J. Increased life expectancy resulting from addition of L-deprenyl to madopar treatment in Parkinson's disease: a long-term study. J Neural Transm 1985;64:113-127.
15. Tetrud JW, Langston JW. The effect of deprenyl (selegiline) in the natural history of Parkinson's disease. Science 1989;245:519-522.
16. The Parkinson's Disease Study Group. Effect of deprenyl on the progression of disability in early Parkinson's disease. N Engl J Med 1989;321:1364-1371.
17. Girmen AS, Baenziger J, Hotamisligil GS, et al. Relationship between platelet monoamine oxidase B activity and alleles at the MAOB locus. J Neurochem 1992;59:2063-2066.
18. Hotamisligil GS, Girmen AS, Fink JS, et al. Hereditary variations in monoamine oxidase as a risk factor for Parkinson's disease. Mov Disord 1994;9:305-310.
19. Krontiris TG, Minisatellites and human disease. Science 1995;269: 1682-1683.
20. Epplen JT, Kyas A, Maueler W. Genomic simple repetitive DNAs are targets for differential binding of nuclear proteins. FEBS Lett 1996,389:92-95.
21. Epplen C, Santos EJ, Maueler W, van Helden P, Epplen JT. On simple repetitive DNA sequences and complex diseases. Electrophoresis 1997;18:1577-1585.
22. Richards RI, Sutherland GR. Dynamic mutation: possible mechanisms and significance in human disease. Trends Biochem Sci 1997;22:432-436.
23. Steventon GB, Sturman SG, Heafield MTE, Waring RH, Napier J, Williams AC. Platelet monoamine oxidase activity in Parkinson's disease. J Neural Transm 1989;1:255-261.
24. Steventon G, Humfrey C, Sturman S, Waring RH, Williams AC. Monoamine oxidase B and Parkinson's disease [Letter]. Lancet 1990;1:180.
25. Checkoway H, Costa LG, Woods JS, Castoldi AF, Lund BO, Swanson PD. Peripheral blood cell activities of monoamine oxidase B and superoxide dismutase in Parkinson's disease. J Neural Transm [P-D Sect] 1992;4:283-290.
26. Jarman J, Glover V, Sandler M, Turjanski N, Stern G. Platelet monoamine oxidase B activity in Parkinson's disease: a reevaluation. J Neural Trans [P-D Sect] 1993;5:1-4.